Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Ligand for the NKG2D receptor, together with at least ULBP1 and ULBP3. Additionally we are shipping ULBP2 Kits (26) and ULBP2 Proteins (12) and many more products for this protein.
Showing 10 out of 38 products:
By suppressing AR and up-regulating ULBP2 in HCC (show FAM126A Antibodies), cisplatin could up-regulate cytotoxicity of NK cells to better target HCC (show FAM126A Antibodies).
human tumor cells lost their surface expression of ULBP2, but not ULBP1 (show ULBP1 Antibodies) and ULBP3 (show ULBP3 Antibodies), during NK cell-mediated cytolysis.
This study suggests that NKG2D (show KLRK1 Antibodies) ligands shedding of MICA (show MICA Antibodies), MICB (show MICB Antibodies) and ULBP-2 is a novel pathway in endometriosis complex pathogenesis that impairs Natural Killer Cells cell function.
Varicella-Zoster Virus differentially modulates expression of the NKG2D (show KLRK1 Antibodies) ligands by upregulating MICA (show MICA Antibodies) expression and reducing ULBP2 and ULBP3 (show ULBP3 Antibodies) expression in the infected cells.
A conserved WW domain (show DRP2 Antibodies)-like motif regulates CD74 (show CD74 Antibodies) antigen-dependent cell-surface transport of the NKG2D (show KLRK1 Antibodies) ligand ULBP2.
NKG2D (show KLRK1 Antibodies) and NKG2DL are involved in allergen-induced activation of dendritic epidermal T cells and the NKG2D (show KLRK1 Antibodies)/NKG2DL pathway might be a potential target for treatment of contact hypersensitivity.
Human anaplastic thyroid carcinoma cells are sensitive to NK cell-mediated lysis via ULBP2/5/6 and chemoattract NK cells.
Data inticate that heat shock protein 60 (HSP60 (show HSPD1 Antibodies)) interacted constitutively with NKG2D (show KLRK1 Antibodies) ligand ULBP2 and phosphatase of regenerating liver 3 (PRL-3) regulated HSP60 (show HSPD1 Antibodies) tyrosine phosphorylation.
Results suggest that ULBP2 is expressed and released from cervical cancer cells by CRF (show CRH Antibodies), which regulates NKG2D (show KLRK1 Antibodies) expression in natural killer cells.
c-Cbl (show CBL Antibodies) regulates MICA (show MICA Antibodies)- but not ULBP2-induced NKG2D (show KLRK1 Antibodies) down-modulation in human NK cells.
Ligand for the NKG2D receptor, together with at least ULBP1 and ULBP3. ULBPs activate multiple signaling pathways in primary NK cells, resulting in the production of cytokines and chemokines. Binding of ULBPs ligands to NKG2D induces calcium mobilization and activation of the JAK2, STAT5, ERK and PI3K kinase/Akt signal transduction pathway. In CMV infected cells, interacts with soluble CMV glycoprotein UL16. The interaction with UL16 blocked the interaction with the NKG2D receptor, providing a mechanism by which CMV infected cells might escape the immune system. UL16 also causes ULBP2 to be retained in the ER and cis- Golgi apparatus so that it does not reach the cell surface.
, NKG2D ligand 2
, UL16-binding protein 2
, retinoic acid early transcript 1 H
, retinoic acid early transcript 1H